Regulation & policy
FDA considers rulemaking and enforcement discretion on DSHEA disclaimer
In a letter to the dietary supplements industry, the FDA’s deputy commissioner for human foods says the agency is considering a regulatory amendment regarding requirements around the DSHEA disclaimer on product labels.
Guest article
When transparency becomes selective: GRAS vs. dietary supplement listings
Transparency has suddenly become one of the most talked-about themes in today’s food and consumer safety debates. Policymakers are pressing for more visibility into the ingredients entering the food supply, and the momentum behind reforming the...
‘Misleading and unethical’: Brands caught claiming to ‘treat’ neurodivergent traits
The Advertising Standards Authority (ASA) announced several rulings against supplement brands targeting Autistic consumers and those with attention deficit hyperactivity disorder (ADHD).
‘There was never a dull moment’: 8 reasons to attend the IPA World Congress + Probiota 2026
The IPA World Congress + Probiota 2026 is just two months away! The leading event for the probiotics, prebiotics and microbiome community is a must-attend event, and let us tell you why…
FDA reinstates NDI status of NMN with new letters to ingredient players
The U.S. Food and Drug Administration has sent letters to specific NMN ingredient suppliers confirming it has set aside previous determinations that the vitamin B3 form is excluded from the definition of a dietary supplement.
Guest article
Welcoming the age of MAHA with persistence, patience and pragmatism
What a year of transition, uncertainty and unpredictability 2025 has been—not just for the dietary supplement industry, but for all of us navigating rapid change. From shifting tariff rates to upheaval at FDA, from renewed pushes to restrict access to...
New NIH initiative boosts systems-based nutrition research
The National Institutes of Health has launched a five-year project to develop a unified model of healthy human physiology, signaling a shift toward whole-person health that aligns with longstanding approaches in the nutrition and supplements sector.
NutraCast: How US trade policy is disrupting the supplement supply chain, threatening quality
Tariffs meant to boost U.S. manufacturing might actually be pushing companies away from American investment. Chase Johnston, vice president of operations at Arjuna Natural, breaks down how rapidly shifting tariff rates are creating chaos for the...
The most-read NutraIngredients news in Europe of Fall 2025
The most popular articles on NutraIngredients in Europe this Fall highlighted how science, regulatory bodies, media scrutiny and increasingly educated consumers are shaping safety, searches, claims and trends in the supplement market.
FDA seizes $1 million in 7-OH products
The U.S. Marshals Service has seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products from three firms in Missouri, the U.S. FDA announced.
Coming soon: Current landscape and future directions for prebiotics
Hear from experts from Wageningen University and myota in a free webinar on Dec. 9 that explores the challenges and opportunities of a growing prebiotic category.
Across the Nutraverse: Hi-Tech Pharmaceuticals CEO convicted, Vitamin B6 in Australia, creatine
Catch up with our weekly round-up of key news from across the Nutraverse.
First-ever mycoprotein goes through novel food system successfully
The Protein Brewery is celebrating a positive scientific opinion from Europe’s food safety agency. So when will its new mycoprotein ingredient hit the market?
Regulatory review: Vitamin B6 in Australia, tariff exemption, IPA on self-GRAS
Australia’s implementation of ‘pharmacist-only’ scheme for vitamin B6, the US expanding tariff exemption list to include botanicals like turmeric, and the International Probiotics Association’s efforts in addressing expected changes to the USFDA GRAS...
CRN updates vitamin K2 MK-7 intake limits
The Council for Responsible Nutrition (CRN) has determined a Highest Observed Intake (HOI) level for vitamin K2-MK7 of 375 mcg/day following a review of over 40 clinical trials.
Australia implements ‘pharmacist-only’ scheme for vitamin B6 from Jun 2027
Vitamin B6 supplements with a recommended daily dose of over 50mg but 200mg or less will be sold as ‘pharmacist-only’ products in Australia from June 2027.
SSG 2025: Asa Waldstein on FDA, FTC and NAD enforcement trends
Apex Compliance’s Asa Waldstein shares valuable insights for those seeking to avoid an FDA warning letter, a competitor case with the NAD or a referral to the FTC due to ad claims non-compliance.
News in brief
HHS brings back NHANES staff for public health
The Department of Health and Human Services (HHS) has rescinded the reduction in force notices for staff involved with the National Health and Nutrition Examination Survey (NHANES) following public pressure to recognize the importance of the survey for...
規制レビュー：偽造品、成分不一致、NMNのステータス
マレーシア企業Holista Colltechが自社オメガ3製品の偽造問題を受け規制当局への強い働きかけを要請、オーストラリア規制当局が輸入メラトニンサプリメントの成分不一致を指摘、米国FDAがNMNのサプリメントとしての合法性を宣言―規制関連ニュースの最新動向をまとめました。
3 crucial steps to harmonise halal standards across regions
Halal food trade faces challenges in regional, much less global, standardisation – experts outline three key steps to move toward a unified system
Michigan legislator introduces restrictive supplements bill
A lawmaker in Michigan has filed a bill to prohibit the sale of weight loss and muscle building products to minors. The Council for Responsible Nutrition said the bill is “premised on a misunderstanding of both the science and the regulation of dietary...
EFSA sets safe limit for Delta-8 THC
The European Food Safety Authority (EFSA) has suggested a safe limit of 1 µg/kg body weight for the combined intake of delta-8 and delta-9 THC from food.
White House updates tariffs with relief for some botanicals
The Trump Administration has revised and expanded the tariff exemption list to include botanicals such as green and black tea, cinnamon, ginger and turmeric.
Founder urges women’s health brands to lobby against red tape
The founder of premium women’s health supplement brand Lyma signaled an opportunity for UK brands to contest health claim restrictions during last week’s Nutra Healthspan Summit.
监管审查：假冒产品、含量不符、 NMN 合法化
本期监管动态为您带来最新进展，包括马来西亚公司 Holista Colltech 因旗下 Omega-3 产品遭遇假冒问题呼吁行业加强与监管机构沟通、澳大利亚监管机构警示进口褪黑素补充剂含量不符问题、美国 FDA 宣布 NMN 可作为膳食补充剂合法使用。
CHPA’s MacKay on growth, challenges, MAHA and going mainstream
The Dietary Supplement Health and Education Act (DSHEA) was signed into law in 1994 by President Bill Clinton, creating the modern dietary supplements industry as we know it. When DSHEA passed, the industry had 4K products and was worth $4 billion....
New lipid gets EFSA novel food approval, and it cuts cholesterol
Food and drink manufacturers now have a new lipid to add to their formulation toolbox – one that boasts health and sustainability credentials
IPA chief on the end of self-GRAS, China’s probiotic growth and global regulatory uncertainty
The International Probiotics Association (IPA) has mobilized its regulatory affairs committee to address expected changes to the GRAS affirmation pathway. “We’ve been very active, proactive,” says George Paraskevakos.
CRN’s Mister on the regulatory curveball nobody saw coming
The Trump Administration returned to the White House one year ago. From Robert F. Kennedy Jr. being named health secretary, to tariffs, to Make America Healthy Again, it’s been an eventful year for a variety of sectors—including dietary supplements.
ANH pushes FDA to broaden access to medical foods
The Alliance for Natural Health (ANH) USA is calling for FDA regulatory reform to broaden access to medical foods, with the aim of using nutrition therapies to help manage chronic disease and other conditions.
Regulation expert: EFSA’s search for ‘risk free guarantee’ from CBD leading to illegal products and loss of engagement
The European Food Safety Authority (EFSA) has issued a negative opinion on the use of synthetic cannabidiol (CBD) in food supplements, leading to questions over the future of the market.
AHPA’s Rigby on tariffs, tech and access
The herbal sector is facing unprecedented challenges—and opportunities—that could reshape how Americans access natural products.
NAD+ health ads scrutinized as NAD recommends Reus Research modify or discontinue certain claims
The National Advertising Division (NAD) has recommended that Reus Research LLC modify or discontinue several advertising claims related to its Cata-Kor NAD+ Core and Advanced dietary supplements.
Fabricant on government shutdown, NMN and 90 years of NPA
The ongoing government shutdown is impacting GMP inspections and delaying proposals to amend the Generally Recognized as Safe (GRAS) regulation. “We’re gonna just sit on our hands for a little while longer,” says Dr. Daniel Fabricant, president and CEO...
Is kratom tarnishing kava’s reputation?
Consumer priorities have undergone a major shift in recent years, with mental wellness emerging as a top concern. Given the focus on mental health, it may not be surprising that demand for functional beverages like kava are on the rise.
FDA flags more supplements adulterated with toxic yellow oleander
The US Food and Drug Administration (FDA) has updated its ongoing safety alert regarding dietary supplements adulterated with yellow oleander, expanding its watchlist following analytical testing.
Nutracast: The push for nutrition education in medical school
Despite nutrition playing a critical role in preventing chronic diseases, the subject is not sufficiently incorporated into medical education. However, a movement is underway to change that.
TGA to work on updating guidance for listed medicines permitted indications
Australia’s Therapeutic Goods Administration (TGA) has plans to update guidance around permitted indications for listed medicines, amongst others, as part of upcoming plans for year 2025/2026.
What can brands say about mind health supplements under EU Law?
Brands formulating mind health supplements face a legal minefield in the EU, as strict health-claim rules and fragmented national laws severely limit what they can say about key ingredients.
‘Confusing’ and ‘shocking’: Elimination of lawful marketing leaves regulatory experts with more questions than answers
During the Council for Responsible Nutrition (CRN) Convergence ‘25 Conference, a panel dissected the FDA’s Sept. 29 response to citizen petitions regarding dietary supplement regulations. While nicotinamide mononucleotide (NMN) received some regulatory...
Regulatory review: Counterfeits, content discrepancies and NMN’s status
Malaysia firm Holista Colltech urging stronger voice with regulatory authorities amid counterfeits of its omega-3 products, Australia’s regulator flagging content discrepancies in imported melatonin supplements and U.S. FDA declaring NMN lawful in...
Holista Colltech urges stronger voice among industry players amid counterfeit case
Malaysia-based Holista Colltech is urging industry stakeholders to have a stronger voice with regulatory authorities amid a counterfeit case involving its omega-3 supplements.
Q&A: Supplement brands face new AI decision-making rules
The California Consumer Privacy Act (CCPA) has implications for dietary supplement stakeholders. In this Q&A, Nikki Bhargava, a partner in the Emerging Technologies group at global law firm Reed Smith breaks down what you need to know.
Trend tracker: Q-commerce, ‘proteinification’, magnesium in the spotlight
Find out more about India’s quick-commerce boom, ‘proteinification’ in food and drinks, and what’s driving the popularity of magnesium supplements in Australia.